OBJECTIVE: Steroidogenic factor 1 (SF1), officially designated NR5A1, is a nuclear receptor that plays key roles in endocrine development and function. Previous reports of human SF1 mutations revealed a spectrum of phenotypes affecting adrenal function and/or gonadal development and sex differentiation. We present the clinical phenotype and functional effects of a novel SF1 mutation. PATIENT: The patient is a 22-year-old 46, XY Japanese patient who presented with dysgenetic testes, atrophic vasa deferentia and epididymides, lack of Müllerian structures, and clitoromegaly. Endocrine studies revealed normal adrenal function. RESULTS: Analysis of the SF1 gene revealed compound heterozygosity for a previously described p.G146A polymorphism and a novel missense mutation (p.R84C) in the accessory DNA-binding domain. The father carried the p.G146A polymorphism and the mother had the p.R84C mutation; both were clinically and reproductively normal. Functional studies demonstrated that the p.R84C SF1 had normal nuclear localization but decreased DNA-binding affinity and transcriptional activity compared with wild-type SF1; it did not exhibit any dominant negative activity. CONCLUSIONS: These results describe the human phenotype that results from compound heterozygosity of the p.G146A polymorphism and a novel p.R84C mutation of SF1, thereby extending the spectrum of human SF1 mutations that impair testis development and sex differentiation in a sex-limited manner while preserving normal adrenal function.
OBJECTIVE:Steroidogenic factor 1 (SF1), officially designated NR5A1, is a nuclear receptor that plays key roles in endocrine development and function. Previous reports of humanSF1 mutations revealed a spectrum of phenotypes affecting adrenal function and/or gonadal development and sex differentiation. We present the clinical phenotype and functional effects of a novel SF1 mutation. PATIENT: The patient is a 22-year-old 46, XY Japanese patient who presented with dysgenetic testes, atrophic vasa deferentia and epididymides, lack of Müllerian structures, and clitoromegaly. Endocrine studies revealed normal adrenal function. RESULTS: Analysis of the SF1 gene revealed compound heterozygosity for a previously described p.G146A polymorphism and a novel missense mutation (p.R84C) in the accessory DNA-binding domain. The father carried the p.G146A polymorphism and the mother had the p.R84C mutation; both were clinically and reproductively normal. Functional studies demonstrated that the p.R84CSF1 had normal nuclear localization but decreased DNA-binding affinity and transcriptional activity compared with wild-type SF1; it did not exhibit any dominant negative activity. CONCLUSIONS: These results describe the human phenotype that results from compound heterozygosity of the p.G146A polymorphism and a novel p.R84C mutation of SF1, thereby extending the spectrum of humanSF1 mutations that impair testis development and sex differentiation in a sex-limited manner while preserving normal adrenal function.
Authors: Liying Gao; Youngha Kim; Bongki Kim; Stacey M Lofgren; Jennifer R Schultz-Norton; Ann M Nardulli; Leslie L Heckert; Joan S Jorgensen Journal: Biol Reprod Date: 2010-10-20 Impact factor: 4.285
Authors: Diana Lourenço; Raja Brauner; Lin Lin; Arantzazu De Perdigo; Georges Weryha; Mihaela Muresan; Radia Boudjenah; Gil Guerra-Junior; Andréa T Maciel-Guerra; John C Achermann; Ken McElreavey; Anu Bashamboo Journal: N Engl J Med Date: 2009-02-25 Impact factor: 91.245
Authors: Joyce Y Wu; Ivan N McGown; Lin Lin; John C Achermann; Mark Harris; David M Cowley; Salim Aftimos; Kristen A Neville; Catherine S Choong; Andrew M Cotterill Journal: Clin Endocrinol (Oxf) Date: 2013-04 Impact factor: 3.478